Onderneming Mallinckrodt OTC Markets

MNKKQ

IE00BBGT3753

Managers

Besturend

Aandelenklasse

Participaties

Bedrijfsgegevens

Bedrijven van de groep

Sector

Sector Farmaceutische producten - Andere

Inactief instrument

Mallinckrodt plc ontwikkelt, produceert, verkoopt en distribueert merk- en generieke farmaceutische specialiteiten en therapieën. Het bedrijf opereert in twee rapporteerbare segmenten: Specialty Brands en Specialty Generics. Specialty Brands omvat farmaceutische specialiteitenmerken. Specialty Generics omvat generieke nichegeneesmiddelen en werkzame farmaceutische bestanddelen. Het segment Specialty Generics richt zich op het leveren van speciale generieke geneesmiddelen en actieve farmaceutische ingrediënten (API's) aan haar klanten. Het bedrijf richt zich op verschillende therapeutische gebieden, zoals auto-immuunziekten en zeldzame ziekten in specialistische gebieden zoals neurologie, reumatologie, hepatologie, nefrologie, pulmonologie, oogheelkunde en oncologie; immuuntherapie en neonatale respiratoire kritieke zorgtherapieën; pijnstillers, gekweekte huidvervangers en gastro-intestinale producten. Het productassortiment omvat Acthar Gel, INOmax, Therakos fotoferese, StrataGraft, Terlivaz en Amitiza.

Aantal werknemers: 2 786

Managers	Titel	Leeftijd	Van
Sigurdur Olafsson CEO	Chief Executive Officer	55	25-06-22
Bryan Reasons DFI	Director of Finance/CFO	56	18-03-19
Kassie Harrold CMP	Compliance Officer	45	-
Peter Richardson CTO	Chief Tech/Sci/R&D Officer	64	12-01-23
Derek Belz IRO	Public Communications Contact	-	01-04-22
Daniel J. Speciale IRC	Investor Relations Contact	-	01-01-13
Lisa French PRN	Corporate Officer/Principal	55	-
Jason Goodson PRN	Corporate Officer/Principal	43	-
Mark Tyndall LAW	General Counsel	48	01-06-14
Stephen Andrew Welch PRN	Corporate Officer/Principal	47	-

Besturend	Titel	Leeftijd	Van
Wesley Wheeler BRD	Director/Board Member	68	02/02
Paul Bisaro CHM	Chairman	63	16-06-22
Sigurdur Olafsson CEO	Chief Executive Officer	55	25-06-22
David Stetson BRD	Director/Board Member	67	14/11
Shah Hussain BRD	Director/Board Member	59	02/02
Katina Dorton BRD	Director/Board Member	66	02/02
Jon Zinman BRD	Director/Board Member	44	14/11

	Stemming	Aantal	Vrij verhandelbaar	Bedrijfseigen aandelen	Drijvend Totaal
Aandeel A	1	19 696 335	19 696 335 ( 100,00 %)	0	100,00 %

Naam	Aandelen	%	Totale waarde
SILENCE THERAPEUTICS PLC 4.70%	5 063 859	4.70%	4 456 196 $

Mallinckrodt Plc

College Business & Technology Park Cruiserath

15, Blanchardstown

+353 1 696 0000

http://mallinckrodt.com

Naam	Categorie en sector
Sucampo Pharma LLC Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan.	Miscellaneous Commercial Services
Sucampo GmbH Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The private company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million.	Pharmaceuticals: Major
Mallinckrodt Group SARL
Mallinckrodt Windsor SARL Mallinckrodt Windsor SARL Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Windsor SARL provides pharmaceutical products. The private company is based in Luxembourg, Luxembourg.	Pharmaceuticals: Major
Mallinckrodt International Holdings SARL Mallinckrodt International Holdings SARL Financial ConglomeratesFinance Part of Mallinckrodt Plc, Mallinckrodt International Holdings SARL functions as an investment holding Luxembourger company. The private company is based in Luxembourg, Luxembourg.	Financial Conglomerates
Mallinckrodt Pharmaceuticals Ltd. Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Staines Upon Thames, UK and was founded in 2015.	Pharmaceuticals: Major

Gezondheidszorg

Farmaceutisch en medisch onderzoek

Farmaceutische producten

Farmaceutische producten

Farmaceutische producten - Andere

	Vaira. 1 jan.	Kapi.
ELI LILLY AND COMPANY	+26,00%	653 mld.
NOVO NORDISK A/S	+27,00%	556 mld.
JOHNSON & JOHNSON	-6,61%	354 mld.
MERCK & CO., INC.	+20,60%	331 mld.
ABBVIE INC.	+2,73%	296 mld.
ASTRAZENECA PLC	+13,09%	233 mld.
NOVARTIS AG	+5,46%	201 mld.
ROCHE HOLDING AG	-9,61%	193 mld.
AMGEN INC.	-5,95%	144 mld.

Farmaceutische producten - Andere